Vitamin D and HIV-1 Resistance in Female Genital Epithelial Cells

A 2.3 MB research document authored by Sandra M. Gonzalez and last updated in April 2026 details a study on Vitamin D's role in HIV-1 resistance. The document describes experiments where pre-treatment of endocervical, ectocervical, and vaginal epithelial cell lines with Vitamin D reduced HIV-1 infection of CD4+ T cells by up to 53%. Findings suggest the antiviral effect is linked to increased expression and secretion of the cathelicidin antimicrobial peptide (CAMP).

Use Cases

• Analyzing the correlation between Vitamin D treatment and HIV-1 infectivity reduction based on described experimental results.
• Studying the role of cathelicidin (CAMP) expression as an antiviral mechanism in female genital epithelium.
• Comparing the differential effects of Vitamin D on HIV-1 transmigration across distinct epithelial cell lines (End1, Ect1, Vk2).
• Investigating the modulation of epithelial barrier functions, such as tight junction integrity, in response to Vitamin D.

Strengths

• Document is under a permissive CC-BY-4.0 license, allowing for broad reuse.
• The description provides specific quantitative results, such as a 50% reduction in HIV-infection for End1 cells after Vitamin D treatment.
• The study investigates three distinct female genital epithelial cell lines, allowing for comparative analysis.

Limitations

• The primary data format is a DOCX file, which may require parsing to extract structured information.
• Row count and column-level documentation are unknown, limiting suitability assessment for direct computational analysis.
• The dataset's scale is small at 2.3 MB, suggesting it contains a research document rather than extensive raw data.

Provenance

Source

Sandra M. Gonzalez via figshare

Collection Method

Experimental data from in vitro cell culture studies using epithelial cell lines and HIV-1.

Freshness

Last updated 2026-04-17 04:12:00